Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecile L Maire

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Neuro-Oncology|October 25, 2014
Molecular pathologic diagnosis of epidermal growth factor receptorCecile L Maire, Keith L Ligon
CNS Drugs|August 10, 2017
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled PromiseManfred Westphal, Cecile L Maire, Katrin Lamszus
Brain Sciences|August 28, 2025
Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic InnovationsJoshua H Liu, Maksym Horiachok, Santosh Guru, et al.
Cancers|December 24, 2021
CRISPR-to-Kill (C2K)-Employing the Bacterial Immune System to Kill Cancer CellsDawid Głów, Cecile L Maire, Lea Isabell Schwarze, et al.
Plos One|September 4, 2014
Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomasKarl Holmberg Olausson, Cecile L Maire, Sam Haidar, et al.
Cancer Immunology Research|July 4, 2019
Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade GliomasMichael Bockmayr, Frederick Klauschen, Cecile L Maire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
Optical Barcoding for Single-Clone Tracking to Study Tumor HeterogeneityMalte Mohme, Cecile L Maire, Kristoffer Riecken, et al.
Plos One|November 26, 2009
CRX is a diagnostic marker of retinal and pineal lineage tumorsSandro Santagata, Cecile L Maire, Ahmed Idbaih, et al.
International Journal of Molecular Sciences|July 29, 2023
Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPsMax Wichmann, Cecile L Maire, Niklas Nuppenau, et al.
Neuro-Oncology|July 28, 2018
The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effectsAnnegret Kathagen-Buhmann, Cecile L Maire, Jonathan Weller, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Neuro-Oncology|October 25, 2014
Molecular pathologic diagnosis of epidermal growth factor receptorCecile L Maire, Keith L Ligon
CNS Drugs|August 10, 2017
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled PromiseManfred Westphal, Cecile L Maire, Katrin Lamszus
Brain Sciences|August 28, 2025
Unraveling Glioblastoma Heterogeneity: Advancing Immunological Insights and Therapeutic InnovationsJoshua H Liu, Maksym Horiachok, Santosh Guru, et al.
Cancers|December 24, 2021
CRISPR-to-Kill (C2K)-Employing the Bacterial Immune System to Kill Cancer CellsDawid Głów, Cecile L Maire, Lea Isabell Schwarze, et al.
Plos One|September 4, 2014
Prominin-1 (CD133) defines both stem and non-stem cell populations in CNS development and gliomasKarl Holmberg Olausson, Cecile L Maire, Sam Haidar, et al.
Cancer Immunology Research|July 4, 2019
Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade GliomasMichael Bockmayr, Frederick Klauschen, Cecile L Maire, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 23, 2017
Optical Barcoding for Single-Clone Tracking to Study Tumor HeterogeneityMalte Mohme, Cecile L Maire, Kristoffer Riecken, et al.
Plos One|November 26, 2009
CRX is a diagnostic marker of retinal and pineal lineage tumorsSandro Santagata, Cecile L Maire, Ahmed Idbaih, et al.
International Journal of Molecular Sciences|July 29, 2023
Deep Characterization and Comparison of Different Retrovirus-like Particles Preloaded with CRISPR/Cas9 RNPsMax Wichmann, Cecile L Maire, Niklas Nuppenau, et al.
Neuro-Oncology|July 28, 2018
The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effectsAnnegret Kathagen-Buhmann, Cecile L Maire, Jonathan Weller, et al.
Pageof 5